Related Experiment Video
Updated: Aug 9, 2026

3-D Imaging and Analysis of Neurons Infected In Vivo with Toxoplasma gondii
Published on: December 9, 2014
Symptomatic toxoplasma infection due to congenital and postnatally acquired infection
1Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, London, UK. ruth.gilbert@ich.ucl.ac.uk
Insights
Symptomatic toxoplasma infection in children is rare, with congenital cases accounting for a low incidence. Primary prevention strategies should focus on childhood acquisition, as it significantly contributes to ocular disease.
Area of Science:
- Pediatric Infectious Diseases
- Ophthalmology
- Epidemiology
Background:
- Toxoplasma infection can occur congenitally or postnatally, leading to various symptoms, including ocular manifestations.
- Understanding the incidence and severity of symptomatic toxoplasmosis in children is crucial for public health strategies.
Purpose of the Study:
- To determine the incidence and severity of symptomatic toxoplasma infection in children, differentiating between congenital and postnatally acquired cases.
- To inform current screening and prevention policies for toxoplasmosis in the UK and Ireland.
Main Methods:
- A surveillance study involving newly diagnosed children (<16 years) with signs/symptoms of toxoplasmosis between 2002-2004.
- Cases were reported by clinicians to surveillance units or referral laboratories, with confirmation based on clinical and serological findings.
Main Results:
- Thirty-eight children had confirmed toxoplasma infection.
- Congenital toxoplasmosis incidence was 1.62/100,000 live births; 9% were stillborn, 32% had intracranial abnormalities/developmental delay, and 45% had retinochoroiditis.
- Postnatally acquired infection occurred in 16 children, all presenting with retinochoroiditis.
Conclusions:
- The low burden of symptomatic congenital toxoplasmosis does not support current prenatal/neonatal screening policies.
- Primary prevention should target childhood acquisition, which accounts for half of pediatric ocular toxoplasmosis in the UK and Ireland.
Aims:
To determine the incidence and severity of symptomatic toxoplasma infection presenting during childhood due to congenital or postnatally acquired infection.
Methods:
Between 2002 and 2004, newly diagnosed children (<16 years) with signs or symptoms of congenital or ocular toxoplasmosis were reported by clinicians to the British Paediatric and Ophthalmic Surveillance Units or by toxoplasma referral laboratories. Confirmed cases were estimated to have a greater than 50% probability of congenital and/or ocular toxoplasmosis, based on clinical and serological findings.
Results:
Thirty eight children had confirmed toxoplasma infection. Twenty two (58%) were classified with congenital infection (cumulative incidence for England and Wales 1.62[corrected]/100,000 live births; 95% CI 0.85[corrected] to 2.83[corrected]), of whom 2 (9%) were stillborn, 7 (32%) live births had intracranial abnormalities and/or developmental delay (5 of whom had retinochoroiditis), and 10 (45%) had retinochoroiditis with no other abnormalities reported. A further 16 (42%) children were classified as infected after birth; all had retinochoroiditis.
Conclusions:
The low burden of symptomatic congenital toxoplasmosis combined with the lack of evidence of an effective treatment support current policy not to offer prenatal or neonatal screening for toxoplasma infection. Primary prevention strategies need to address acquisition of infection in childhood which accounts for half the ocular disease due to toxoplasma infection in children in the UK and Ireland.
More Related Videos
11:21Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
Published on: March 12, 2015
11:17Obtaining Highly Purified Toxoplasma gondii Oocysts by a Discontinuous Cesium Chloride Gradient
Published on: November 3, 2009
Related Concept Videos
Toxoplasmosis
American Trypanosomiasis
Amebiasis
Cytomegalovirus Disease
Sexually Transmitted Infections
Teratogenicity